STAY-CLEAN I/E

SECTION 2: Hazards identification

OSHA EMERGENCY OVERVIEW WARNING! May cause eye irritation.

Principle Routes of Exposure

Eye and skin contact, ingestion, inhalation TARGET ORGANS: Eye, kidney, central nervous system

Medical Conditions Generally Aggravated by Exposure

Unknown

Potential health effects

EYE CONTACT: This product may produce irritation upon contact with the eye. SKIN CONTACT: This product may produce minor irritation upon skin contact. This product is not expected to be absorbed through the skin in harmful amounts or to cause skin sensitization. Repeated skin contact with ethylene glycol may, in a very small proportion of cases, cause sensitization with the development of allergic contact dermatitis. 3. (Cont’d) INGESTION: This product would be expected to be moderately toxic by ingestion. Ingestion of large volumes of ethylene glycol may result in central nervous system depression and kidney damage. Cardiac failure and pulmonary edema may develop. Early to moderate CNS depression may be evidenced by changes in urine output, urine appearance or edema (swelling from fluid retention). INHALATION: This product is not expected to present an inhalation hazard unless mists or vapors are generated. Significant air concentrations are not achieved unless the product is heated or sprayed as a mist. Inhalation of product mist may cause irritation of the nose and throat with headache, tearing and coughing. High vapor concentrations of ethylene glycol caused, for example, by heating the product in an enclosed and poorly ventilated workplace, may produce irritation of upper respiratory tract, nausea, vomiting, headache, dizziness, and irregular eye movements. SUBCHRONIC, CHRONIC: No applicable information was found concerning any potential health effects resulting from subchronic or chronic exposure to the product. Repeated inhalation of ethylene glycol mist may produce signs of central nervous system involvement, particularly dizziness and nystagmus (rhythmical oscillation of the eyeballs, either horizontal, rotary, or vertical.) In one study, when ethylene glycol was administered in the diet at daily doses up to 1.0 g/kg to pregnant rats, no maternal toxicity, no embryotoxicity nor teratogenicity were observed. In a more recent study, when ethylene glycol was administered by gavage at daily doses of 1.25 g/kg and above to pregnant rats, or at 750 mg/kg and above to pregnant mice, there was an increase in the number of malformed fetuses at all dose levels. Except at the lowest dose level in mice, there was also evidence of maternal toxicity at all dose levels. Observations suggest that ethylene glycol is to be regarded as an animal teratogen; there is currently no available information to suggest that ethylene glycol has caused birth defects in humans. CARCINOGENICITY: NTP: No ingredients listed in this section. LARC: No ingredients listed in this section. OSHA: No ingredients listed in this section.